Abstract:Objective To investigate the diagnostic value of ADC for breast lesions with different enhancement shape or mass size. Methods One hundred and thirty-six breast lesions confirmed by histopathology were included in this study. According to enhancement shape and size of the lesion, all lesions were divided into 3 groups: non-masslike enhancement ( G1 ), masslike enhancement with the largest diameter ＜ 2. 0 cm (G2a) and masslike enhancement with the largest diameter ＞ 2. 0 cm (G2b). Echo planar imaging DWI was performed and three b-values (0,500 and 1000 s/mm2) were applied. The t-test was used for testing the difference of ADC between malignant and non-malignant breast lesions in each group. ROC curve was deduced to test the diagnostic efficiency of ADC. The sensitivity, specificity, negative predictive value( NPV), positive predictive value(PPV) and accuracy of ADC for the diagnosis of breast lesions were calculated under the different threshold. Appropriate b value and threshold were determined with the combination of morphologic evaluation. Results There were no significant differences for the mean ADC values between malignant [b =800 mm2/s: ADC value = ( 1.13 ±0. 23) × 10-3 mm2/s,b=1000 mm2/s: ADC value = (1.05 ±0.20) × 10-3 mm2/s] and non-malignant breast lesions [b =800 mm2/s: ADC value = ( 1.28 ±0. 27) × 10-3 mm2/s, t = 1. 636, P =0. 112,b = 1000 mm2/s: ADC value=(1.20 ±0.23) × 10-3 mm2/s, t = 1.720, P =0. 109] in Group 1. The mean ADC values of malignant breast lesion [b =800 mm2/s: ADC value = (1.07 ±0. 15) × 10-3 mm2/s,b = 1000 mm2/s:ADC value = (0. 99 ±0. 14) × 10-3 mm2/s] were significantly lower than that of non-malignant lesion [b =800 mm2/s: ADC value = ( 1.37 ± 0. 37 ) × 10-3 mm2/s, t = 4. 803, P = 0. 000; b = 1000 mm2/s: ADC value= (1.30 ±0.34) × 10-3 mm2/s, t =4.227, P =0.000] in Group 2a. The mean ADC values of malignant breast lesion [b =800 mm2/s: ADC value = (0. 97 ±0. 14) × 10-3 mm2/s; b = 1000 mm2/s:ADC value = (0. 93 ±0. 14) × 10-3 mm2/s] were significantly lower than that of non-malignant lesion [b =800 mm2/s: ADC value = ( 1.40 ± 0. 39) × 10 -3 mm2/s, t = 4. 227, P = 0. 000; b = 1000 mm2/s: ADC value = ( 1.35 ±0. 36) × 10-3 mm2/s, t =4. 329, P =0. 000] in Group 2b. The diagnostic efficiency was equal( x2 =0. 36,P =0. 5460) whenever b value of 800 or 1000 s/mm2 was selected. The highest sensitivity (97.7%) and NPV (97. 1%) were obtained with b value of 1000 s/mm2 and threshold of 1.25 ×10 -3 s/mm2. Conclusion MR DWI is useful for the differential diagnosis of breast lesions with masslike enhancement rather than nonmasslike enhancement.

The Diagnostic Value of MR Diffusion Weighted Imaging, Perfusion Weighted Imaging and Dynamic Contrast Enhanced Imaging in Breast Lesions

Diffusion Weighted Imaging and Apparent Diffusion Coefficient Value in Differential Diagnosis of Lymph Node Lesions

The Application of Diffusion-Weighted MR Imaging in Cervical Lymph Node Lesions

Clinical evaluation of combining dynamic contrast-enhanced MR imaging and diffusion-weighted MR imaging for diagnosis of breast lesion

Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI

Differential Diagnostic Value of Diffusion Weighted Imaging at 3.0 T of Benign and Malignancy Breast Lesions

[Diffusion-Weighted Imaging Texture Features in Differentiation of Malignant from Benign Nonpalpable Breast Lesions for Patients with Microcalcifications-Only in Mammography].

Diagnostic Value of Diffusion Weighted Imaging for Breast Lesions at 3.0T MR

The value of dynamic contrast-enhanced magnetic resonance imaging combined with apparent diffusion coefficient in the differentiation of benign and malignant diseases of the breast

Initial Study of Diagnostic Value in Diffusion Weighted Imaging of Breast Neoplasm

Comparative utility of MRI perfusion with MSIDR and DWIBS for the characterization of breast tumors.

Value of Different Conjunctive Approach of Functional MRI in the Diagnosis of Breast Benign and Malignant Lesions

Differential diagnosis of benign and malignant breast masses using diffusion-weighted magnetic resonance imaging

MR diffusion-weighted imaging in differential diagnosis of breast lesions with different enhancement shapes or size and parameter selection

A Prospective Evaluation with T*2W First-Pass Perfusion MRI in Diagnosing Breast Neoplasm

Application of MRI Diffusion Weighted Imaging in the Diagnosis of Breast Cancer

The Role of Diffusion-Weighted Imaging and the Apparent Diffusion Coefficient (ADC) Values for Breast Tumors

MR Diffusion Weighted Imaging with Background Signal Suppression in Breast Cancer

Diffusion-weighted MRI of the Breast: Lesion Characterization and Parameter Selection

The Study of MR Time-signal Intensity Curve in Breast Lesions

Use of Diffusion Kurtosis Imaging and Quantitative Dynamic Contrast-Enhanced MRI for the Differentiation of Breast Tumors